Jacob Ricca
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Co-authors
- Taha Merghoub (9 shared papers)Dmitriy Zamarin (9 shared papers)Jedd D. Wolchok (9 shared papers)Tyler Walther (3 shared papers)Anton Oseledchyk (4 shared papers)Alejandro Jiménez-Sánchez (1 shared paper)Martin L. Miller (1 shared paper)Yanyun Li (1 shared paper)
- Journals
- Molecular Therapy (1 paper)The Journal of Immunology (1 paper)Oncotarget (1 paper)Science Immunology (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Jacob Ricca
12 papers receiving 948 citations
Peers
Comparison fields: 5 of 51
- Oncology 522
- Immunology 364
- Genetics 343
- Reproductive Medicine 58
- Cancer Research 87
Countries citing papers authored by Jacob Ricca
This map shows the geographic impact of Jacob Ricca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Ricca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Ricca more than expected).
Fields of papers citing papers by Jacob Ricca
This network shows the impact of papers produced by Jacob Ricca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Ricca. The network helps show where Jacob Ricca may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacob Ricca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 344 | |
| 2 | 2018 | 126 | |
| 3 | 2018 | 117 | |
| 4 | 2017 | 117 | |
| 5 | 2017 | 114 | |
| 6 | 2017 | 91 | |
| 7 | 2018 | 27 | |
| 8 | 2013 | 24 | |
| 9 | 2018 | 4 | |
| 10 | 2016 | 3 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 1 |
About Jacob Ricca
Jacob Ricca is a scholar working on Oncology, Genetics, Immunology, Molecular Biology and Animal Science and Zoology, having authored 12 papers that have together received 969 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), S100 Proteins and Annexins (2 papers), Immunotherapy and Immune Responses (2 papers), Animal Virus Infections Studies (2 papers), Cancer Mechanisms and Therapy (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Oncology (522 citations), Immunology (364 citations), Genetics (343 citations), Reproductive Medicine (58 citations) and Cancer Research (87 citations). Jacob Ricca has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Taha Merghoub, Dmitriy Zamarin, Jedd D. Wolchok, Tyler Walther, Anton Oseledchyk, Alejandro Jiménez-Sánchez, Martin L. Miller, Yanyun Li, Kay J. Park and Oliver Zivanovic. Their work appears in journals such as Molecular Therapy, The Journal of Immunology, Oncotarget, Science Immunology and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.